A novel chemokine‐based signature for prediction of prognosis and therapeutic response in gliomaWenhua Fan, Ying Zhang, Changyuan Ren et al.|CNS Neuroscience & Therapeutics|2022Cited by 36
MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitorsKenan Zhang, Tao Jiang, Zheng Zhao et al.|Holistic Integrative Oncology|2022Cited by 5